Alberta Investment Management Corp Tg Therapeutics, Inc. Transaction History

Alberta Investment Management Corp

  • $10.2 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$7.81 - $20.45 $493,592 - $1.29 Million
-63,200 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$21.78 - $40.45 $298,386 - $554,165
-13,700 Reduced 17.82%
63,200 $2.1 Million
Q1 2021

May 07, 2021
BUY
$41.61 - $54.3 $3.2 Million - $4.18 Million
76,900 New
76,900 $3.71 Million

Others Institutions Holding TGTX

# of Institutions
335
Shares Held
88.3M
Call Options Held
2.08M
Put Options Held
1.51M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.48B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Alberta Investment Management Corp Portfolio

Follow Alberta Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alberta Investment Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email